Reoperative PEA results in a clear improvement of pulmonary hemodynamics; however, not as significant as with primary surgery, and in-hospital mortality rates are higher ranging between 7.7% and 40%. 39 , 40 , 41 , 42 Given the limited median survival after LTx and the associated immunosuppressive-related complications, the authors plea to always consider redo-PEA in a high-volume center by an experienced PEA surgeon, as this still has the potential to be a truly curative treatment strategy.
1
—
—